One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.

Type 1 diabetes and celiac disease are both immunologic disorders where specific HLA alleles are associated with disease risk. We have developed a radioassay for autoantibodies to tissue transglutaminase (tTG) following the report that this enzyme is 'the' endomysial autoantigen (EMA) of celiac disease. The radioassay for transglutaminase autoantibodies is similar to that utilized for detecting anti-islet autoantibodies. The 'cut-off' for the IgA autoantibody assay was established as 3 x 100th percentile of 184 healthy control subjects at an index of 0.05. Ninety-eight of 847 patients with type 1 diabetes (11.6%) had tissue transglutaminase autoantibodies (tTG). All EMA-positive patients were positive (49/49) for transglutaminase autoantibodies, as were 49/540 EMA-negative patients. Twenty transglutaminase-positive patients consented to intestinal biopsy and 15 biopsies were positive for celiac disease. All patients with a transglutaminase level greater than 0.70 (13/13) had a positive biopsy, while none (0/3) with a level <0.3 had a positive biopsy. The prevalence of transglutaminase autoantibodies was higher in diabetic patients with HLA DQ2 or DQ8. One third of DQ2 homozygous patients (22/68) expressed transglutaminase autoantibodies vs. less than 2% of patients lacking DQ2 or DQ8. A simple radioassay for IgA transglutaminase autoantibodies detects all endomysial antibody positive patients and detects transglutaminase autoantibodies in 5% of endomysial autoantibody negative patients. The prevalence of transglutaminase autoantibodies is associated with DQ2 and DQ8 and in particular DQ2 homozygosity. Autoimmunity to transglutaminase is remarkably prevalent amongst patients with type 1 diabetes expressing certain class II HLA alleles.

[1]  J. Bilbao,et al.  Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers. , 1998, Journal of pediatric gastroenterology and nutrition.

[2]  E. G. de la Concha,et al.  HLA-DQ2-negative celiac disease in Finland and Spain. , 1998, Human immunology.

[3]  C. Acerini,et al.  Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten‐free diet , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[4]  M. Mäki,et al.  High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. , 1997, Scandinavian journal of gastroenterology.

[5]  G. Corrao,et al.  The smaller size of the 'coeliac iceberg' in adults. , 1997, Scandinavian journal of gastroenterology.

[6]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[7]  F. Stevens,et al.  Celiac disease and T-cell lymphoma. , 1996, The New England journal of medicine.

[8]  G. Corrao,et al.  Estimating the incidence of coeliac disease with capture-recapture methods within four geographic areas in Italy. , 1996, Journal of epidemiology and community health.

[9]  J. Ilonen,et al.  Coeliac Disease: Frequent Occurrence After Clinical Onset of Insulin‐dependent Diabetes Mellitus , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[10]  R. Lorini,et al.  Celiac disease and type I (insulin-dependent) diabetes mellitus in childhood: follow-up study. , 1996, Journal of diabetes and its complications.

[11]  Roberto Gianani,et al.  ICA512 Autoantibody Radioassay , 1995, Diabetes.

[12]  H. Erlich,et al.  HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM , 1995, Diabetes.

[13]  C. Catassi,et al.  High prevalence of undiagnosed coeliae disease in 5280 Italian students screened by antigliadin antibodies , 1995, Acta paediatrica.

[14]  J. Lanchbury,et al.  HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. , 1995, Human immunology.

[15]  E. G. de la Concha,et al.  HLA-linked genes acting as additive susceptibility factors in celiac disease. , 1995, Human immunology.

[16]  M. Mäki,et al.  Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. , 1995, Gut.

[17]  M. Babron,et al.  High risk genotypes for celiac disease. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[18]  P. Laippala,et al.  Coeliac disease--associated disorders and survival. , 1994, Gut.

[19]  F. Cucca,et al.  A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. , 1994, Human immunology.

[20]  G. Corrao,et al.  Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. , 1994, Gut.

[21]  E. Thorsby,et al.  T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1∗0501, β1∗0201) heterodimer , 1994 .

[22]  S. Bank,et al.  Clinical gastroenterology. 4th ed , 1994 .

[23]  E. Thorsby,et al.  On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. , 1993, Tissue antigens.

[24]  M. Clark,et al.  Endomysial antibody: is it the best screening test for coeliac disease? , 1992, Gut.

[25]  E. Lebenthal,et al.  Extraintestinal Manifestations and Associated Disorders of Celiac Disease , 1992 .

[26]  R. Rice,et al.  Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  E. Chiocca,et al.  Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. , 1991, The Journal of biological chemistry.

[28]  G. Holmes,et al.  Malignancy in coeliac disease--effect of a gluten free diet. , 1989, Gut.

[29]  T. Vesikari,et al.  Increased prevalence of coeliac disease in diabetes. , 1984, Archives of disease in childhood.

[30]  E. Arranz,et al.  HLA-DQA1*0501 and DQB1*02 homozygosity and disease susceptibility in Spanish coeliac patients. , 1997, Experimental and clinical immunogenetics.

[31]  G. d’Annunzio,et al.  Clinical Aspects of Coeliac Disease in Children with Insulin-Dependent Diabetes Mellitus , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[32]  J. Bodmer,et al.  Nomenclature for factors of the HLA system, 1995. , 1995, Tissue antigens.